39 million Americans live with migraine — a neurological condition, not just a bad headache. A Texas physician explains how migraine is diagnosed and the 2026 treatment landscape, from triptans to CGRP-targeted gepants.
By Dr. Kathryn Kline, MD · Board-Certified Family Medicine Physician · Published 2026-05-14
Roughly 39 million Americans live with migraine — a neurological condition that causes far more than a bad headache. According to CDC data, about 15 percent of U.S. adults experience migraine, and the condition disproportionately affects women, who are three times more likely to suffer from it than men. Despite being one of the most common reasons people visit a primary care doctor, migraine remains widely misunderstood, frequently self-treated, and too often dismissed as something you just push through. The reality is that migraine is a diagnosable, treatable medical condition — and the treatment landscape in 2026 is more effective and more accessible than it has ever been.
Migraine is a neurological disorder, not simply a severe headache. It involves abnormal brain activity that affects nerve signaling, blood vessels, and the chemicals in your brain — most notably a protein called calcitonin gene-related peptide (CGRP), which plays a central role in migraine pain and inflammation.
A migraine attack can last anywhere from 4 to 72 hours untreated, and it typically involves a combination of symptoms that go well beyond head pain:
A migraine is a primary neurological disorder, not just a 'bad headache.' Migraines typically last 4–72 hours and feature moderate-to-severe throbbing pain (often one-sided), nausea or vomiting, and sensitivity to light and sound. Many patients also experience aura (visual disturbances) or warning symptoms hours to days before pain begins. Tension-type headaches, by contrast, are usually a dull, band-like pressure without the associated neurological symptoms.
Common triggers include sleep disruption (too little or too much), skipped meals, dehydration, hormonal shifts (menstrual cycle, perimenopause), stress — and notably the 'let-down' period after stress ends — alcohol (especially red wine), aged cheeses, processed meats containing nitrates, MSG, weather pressure changes, and bright or flickering lights. Trigger patterns are highly individual; a headache diary kept for 4–8 weeks is the most useful diagnostic tool.
See a physician if migraines occur more than 4 days per month, last longer than 72 hours, fail to respond to over-the-counter medication, disrupt work or daily life, or if you are using acute migraine medication (triptans, NSAIDs, acetaminophen) more than 2 days per week — overuse can cause medication-overuse headache. Seek emergency care immediately for a sudden 'worst headache of your life,' a headache with neurological symptoms (weakness, numbness, vision loss, confusion, difficulty speaking), fever with stiff neck, or a headache after a head injury.
Yes — preventive (prophylactic) therapy is recommended when migraines occur 4 or more days per month or significantly impair daily function. Preventive options include beta-blockers (propranolol), topiramate, amitriptyline, CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab), and lifestyle interventions (consistent sleep, hydration, regular meals, trigger management). The 2025 American College of Physicians guideline supports several first-line preventive medications for episodic migraine.
Yes. Migraine is diagnosed clinically based on history — imaging is only needed if red-flag features are present. A telehealth visit allows your physician to take a thorough history, review your headache diary, screen for red flags, prescribe acute and preventive medications when appropriate, and arrange in-person referral or imaging if indicated. At Trinity Family Medicine, migraine evaluation and management is available statewide in Texas via secure video visits starting at $49.99.